INTANGIBLE ASSETS (Tables)

12 Months Ended

Dec. 31, 2013

Intangible assets are comprised of patents acquired in October 2005. Intangible assets, net consisted of the following at December 31:

Intangible assets	2013			2012
Patent - Amlexanox (Aphthasol®)	$	2,090,000		$	2,090,000
Patent - Amlexanox (OraDisc™ A)		6,873,080			6,873,080
Patent - OraDisc™		73,000			73,000
Patent - Hydrogel nanoparticle aggregate		589,858			589,858
		9,625,938			9,625,938
Less: accumulated amortization		(5,955,101	)		(5,479,953	)
Intangible assets, net	$	3,670,837		$	4,145,985

Future aggregate amortization expense for intangible assets

Amortization expense for intangible assets was $475,148 and $476,450 for the years ended December 31, 2013 and 2012, respectively. The future aggregate amortization expense for intangible assets, remaining as of December 31, 2013, is as follows:

Calendar Years	Future Amortization Expense
2014	$	475,148
2015		475,148
2016		476,450
2017		475,148
2018		475,148
2019 & Beyond		1,293,795
Total	$	3,670,837